Oyster Point Pharma, Inc. (OYST) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 194 transactions totaling $83.5M, demonstrating a bullish sentiment with $34.6M in net insider flow. The most recent transaction on Jan 3, 2023 involved a transaction of 8,671 shares valued at $0.
No significant insider buying has been recorded for OYST in the recent period.
No significant insider selling has been recorded for OYST in the recent period.
Based on recent SEC filings, insider sentiment for OYST is bullish with an Insider Alignment Score of 71/100 and a net flow of $34.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Oyster Point Pharma, Inc. (OYST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading OYST stock, having executed 194 transactions in the past 90 days. The most active insider is Clare Ozawa (Executive), who has made 44 transactions totaling $17.2M.
Get notified when executives and directors at OYST file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | G. Atieh Michael | Executive | Disposition | 8,671 | $N/A | $0 | |
| Jan 3, 2023 | G. Atieh Michael | Executive | Tender | 18,063 | $N/A | $0 | |
| Jan 3, 2023 | Christopher Eliades George | Executive | Disposition | 16,863 | $N/A | $0 | |
| Jan 3, 2023 | Christopher Eliades George | Executive | Disposition | 11,761 | $N/A | $0 | |
| Jan 3, 2023 | Lochner Daniel | Executive | Tender | 56,289 | $N/A | $0 | |
| Jan 3, 2023 | Lochner Daniel | Executive | Disposition | 20,236 | $N/A | $0 | |
| Jan 3, 2023 | Anthony Murray Mark | Executive | Disposition | 3,573 | $N/A | $0 | |
| Jan 3, 2023 | Anthony Murray Mark | Executive | Disposition | 118,513 | $N/A | $0 | |
| Jan 3, 2023 | Nau Jeffrey | Executive | Disposition | 1,000 | $N/A | $0 | |
| Jan 3, 2023 | Nau Jeffrey | Executive | Tender | 100,738 | $N/A | $0 | |
| Jan 3, 2023 | Nau Jeffrey | Executive | Disposition | 47,975 | $N/A | $0 | |
| Jan 3, 2023 | Ozawa Clare | Executive | Tender | 414,607 | $N/A | $0 | |
| Jan 3, 2023 | Ozawa Clare | Executive | Tender | 1,003,658 | $N/A | $0 | |
| Jan 3, 2023 | Ozawa Clare | Executive | Tender | 2,465 | $N/A | $0 | |
| Jan 3, 2023 | Ozawa Clare | Executive | Disposition | 11,064 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 18 | $59.0M | 70.0% |
Sale(S) | 12 | $24.5M | 29.0% |
Exercise(M) | 12 | $601.2K | 0.7% |
Payment(F) | 5 | $247.7K | 0.3% |
Disposition(D) | 16 | $0 | 0.0% |
Tender(U) | 16 | $0 | 0.0% |
Award(A) | 36 | $0 | 0.0% |
Other(J) | 57 | $0 | 0.0% |
Conversion(C) | 22 | $0 | 0.0% |
Insiders at Oyster Point Pharma, Inc. are accumulating shares at an accelerated pace. With 27 insiders making 194 transactions totaling $59.0M in purchases versus $24.5M in sales, the net buying activity of $34.6M signals strong executive confidence. Clare Ozawa (Executive) leads the buying activity with $17.2M in transactions across all time.